Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Modes of resistance to anti-angiogenic therapy — Gabriele Bergers (2008) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Modes of resistance to anti-angiogenic therapy
Shared by
Douglas Hanahan
Modes of resistance to anti-angiogenic therapy
Article
2008
en
Authors
GB
Gabriele Bergers
Douglas Hanahan
Related publications
Article
2010
Mechanisms of Resistance to Anti-Angiogenic Therapy and Development of Third-Generation Anti-Angiogenic Drug Candidates
Sonja Loges
,
Thomas Schmidt
,
Peter Carmeliet
Article
2016
Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling
Elizabeth Allen
,
Pascal Miéville
,
Carmen M. Warren
,
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Sadegh Saghafinia
,
Leanne Li
,
Mei-Wen Peng
,
Douglas Hanahan
Article
2005
Anti-Angiogenic and Anti-Inflammatory Effects of Statins: Relevance to Anti-Cancer Therapy
Jozef Dulak
,
Alicja Józkowicz
Article
2013
Modes of action of ipilimumab and biomarkers of resistance to therapy in patients
Dalil Hannani
,
Marie Vétizou
,
David Enot
,
Sylvie Rusakiewicz
,
Sophie Viaud
,
D. Klazmann
,
Nathalie Chaput
,
Alexander M.M. Eggermont
,
Guido Guido Kroemer
,
Caroline Robert
,
Laurence Zitvogel
Article
1998
Anti-HIV combination therapy and resistance management
Anne‐Mieke Vandamme
,
Kristel Van Laethem
,
Kristien Van Vaerenbergh
,
De Clercq Erik
Discussion(0)
No comments yet. Be the first to comment.